ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 32 filers reported holding ELEVATION ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,930,985 | -56.4% | 2,914,255 | 0.0% | 0.55% | -65.8% |
| Q2 2023 | $4,429,668 | +24.9% | 2,914,255 | +56.1% | 1.60% | -18.4% |
| Q1 2023 | $3,546,044 | +100.0% | 1,866,339 | 0.0% | 1.96% | +257.3% |
| Q4 2022 | $1,773,022 | -15.9% | 1,866,339 | 0.0% | 0.55% | +12.7% |
| Q3 2022 | $2,109,000 | -19.3% | 1,866,339 | 0.0% | 0.49% | -34.4% |
| Q2 2022 | $2,613,000 | -60.2% | 1,866,339 | -28.4% | 0.74% | -48.9% |
| Q1 2022 | $6,573,000 | -58.1% | 2,608,167 | 0.0% | 1.46% | -48.5% |
| Q4 2021 | $15,701,000 | -22.7% | 2,608,167 | 0.0% | 2.83% | +39.8% |
| Q3 2021 | $20,318,000 | -42.6% | 2,608,167 | 0.0% | 2.02% | -51.5% |
| Q2 2021 | $35,393,000 | – | 2,608,167 | – | 4.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,370,142 | $1,570,456 | 2.08% |
| Aisling Capital Management LP | 2,834,910 | $1,878,411 | 0.77% |
| venBio Partners LLC | 2,914,255 | $1,930,985 | 0.55% |
| TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $2,650,400 | 0.37% |
| Velan Capital Investment Management LP | 497,299 | $329,510 | 0.27% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $596,340 | 0.11% |
| DAFNA Capital Management LLC | 450,000 | $298,170 | 0.09% |
| Ikarian Capital, LLC | 1,171,939 | $776,527 | 0.09% |
| CAXTON CORP | 21,813 | $14,453 | 0.06% |
| BVF INC/IL | 2,312,200 | $1,532,064 | 0.04% |